• The BT-Reveal Early Pancreatic Cancer Test
  • Fibrinogen (Functional)
  • Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
  • Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, GENESEEQPRIME™, Plasma Complete™)
  • Bilirubin Total, Serum
  • Iron, Serum
  • Partial Thromboplastin Time (PTT)
  • Acute rheumatic fever
  • Colon Cancer Multi-Gene Panel, NGS (ColoNext®, COLONSEQ, COLONSEQPlus)
  • Multi Gene Methylation Assay for Hepatocellular Carcinoma by NGS (HelioLiver™, HelioHCC™ Trace, EarlyDx MethylScan™)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

Diseases (28)
Access to Cancer Antigen (CA) 19-9, Serum is restricted.
Loading...